Predict your next investment

MEDIHERE company logo
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Health & Wellness
medihere.net

See what CB Insights has to offer

Founded Year

2018

Stage

Series A | Alive

Total Raised

$3.38M

Last Raised

$2.7M | 9 mos ago

About MEDIHERE

MEDIHERE operates DoctorHere, a mobile medical O2O platform that offers quick access to medical treatment and surgery by providing doctor recommendations, online appointments, reviews, and health information.

MEDIHERE Headquarter Location

Gwanghwamun Post Office Building 5F 6, Jong-ro, Jongno-gu

Seoul, 03187,

South Korea

+82 070 7847 8910

Latest MEDIHERE News

Medihere lures $2.7 million investment for telemedicine service in US

Nov 12, 2020

닫기 Medihere, a telemedicine provider to ethnic Koreans in the United States, said Thursday that it has attracted 3 billion won ($2.7 million) in investment. Korea Investment Partners (KIP) led the investment, in which Intervest and Wells Investment participated. Medihere’s telemedicine application, “MEDIHERE,” addresses three problems Korean immigrants face when using healthcare services in the U.S., according to the company. Medihere has lured $2.7 million investment into providing telemedicine service to Korean immigrants in the U.S. (Medihere) In the U.S., Korean immigrants spend an average of $10,000 on medical bills a year, the highest in the world. Besides, patients have to wait for about 24.1 days on average to see their doctors. Many ethnic Koreans also have trouble describing their symptoms in English or understanding doctors’ explanations of the treatment. To solve these problems, Medihere provides a membership that can receive unlimited remote treatment and prescription for $119 a year. Members can contact Korean family physicians in five minutes through the platform without standing by or booking a reservation and send a prescription to personally preferred pharmacies. Medihere has provided 20,000 cases of service in six months since it launched the service after the government temporarily allowed remote treatment due to the Covid-19, proving the potential of the telemedicine market and its platform's safety. The company also has grown rapidly, recording a four-fold increase in the number of paid subscribers a month since it launched unlimited telemedicine and prescription service to the U.S. members in September. KIP Managing Director Park Min-sik said that telemedicine services' global demand is increasing rapidly due to the Covid-19 pandemic. Park added that Medihere, which had made significant achievements with the early introduction of its service in Korea, would grow further in the U.S. as Americans have a higher awareness of telemedicine than Koreans. “We plan to expand the telemedicine service for Korean Americans through this investment,” Medihere CEO Kim Ki-han said. “Our goal is to build a healthy Korean society by enhancing access to healthcare with information technology so that all Koreans around the world can receive treatment more easily and conveniently.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MEDIHERE

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MEDIHERE is included in 1 Expert Collection, including Digital Health.

D

Digital Health

9,303 items

Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010

MEDIHERE Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MEDIHERE Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.